Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Critical Care Compendium1001 Topics in Intensive Care & Acute Medicine, pp. 58 - 76Publisher: Cambridge University PressPrint publication year: 2023
References
Bibliography
Cunningham, JA, Jelic, S. Baclofen withdrawal: a cause of prolonged fever in the intensive care unit. Anaesth Intens Care 2005; 33: 534.Google Scholar
Leo, RJ, Baer, D. Delirium associated with baclofen withdrawal: a review of common presentations and management strategies. Psychosomatics 2005; 46: 503.Google Scholar
Leung, NY, Whyte, IM, Isbister, GK. Baclofen overdose: defining the spectrum of severity. Emerg Med Australasia 2006; 18: 77.Google Scholar
Bibliography
Abolnik, I, Lossos, IS, Breuer, R. Spontaneous pneumomediastinum. Chest 1991; 100: 93.Google Scholar
Grotberg, JC, Hyzy, RC, De Cardenas, J, et al. Bronchopleural fistula in the mechanically ventilated patient: a concise review. Crit Care Med 2021; 49: 292.Google Scholar
Maunder, RJ, Pierson, DJ, Hudson, LD. Subcutaneous and mediastinal emphysema: pathophysiology, diagnosis, and management. Arch Intern Med 1984; 144: 1447.Google Scholar
Bibliography
Denburg, JA. Basophil and mast cell lineage in vitro and in vivo. Blood 1992; 79: 846.Google Scholar
Echtenacher, B, Mannel, DN, Hultner, L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 1996; 381: 75.Google Scholar
Bibliography
Allison, TG, Miller, TD, Squires, RW, et al. Cardiovascular responses to immersion in a hot tub in comparison with exercise in male subjects with coronary artery disease. Mayo Clin Proc 1993; 68: 19.Google Scholar
Castle, SP. Public health implications regarding the epidemiology and microbiology of public whirlpools. Infect Control 1985; 6: 418.Google Scholar
Kosatsky, T, Kleeman, J. Superficial and systemic illness related to a hot tub. Am J Med 1985; 79: 10.Google Scholar
Milunsky, A, Ulcickas, M, Rothman, K, et al. Maternal heat exposure and neural tube defects. JAMA 1992; 268: 882.Google Scholar
Bibliography
International Study Group for Behcet’s Disease. Criteria for diagnosis of Behcet’s disease. Lancet 1990; 35: 1078.Google Scholar
Kaklamani, VG, Vaiopoulos, G, Kaklamanis, PG. Behcet’s disease. Semin Arthritis Rheum 1998; 27: 197.Google Scholar
Rosenbaum, M, Rosner, I, Portnoy, E. Remission of Behcet’s syndrome with TNFa blocking treatment. Ann Rheum Dis 2002; 61: 283.Google Scholar
Shimizu, T, Ehrlich, GE, Inaba, G, et al. Behcet’s disease (Behcet’s syndrome). Semin Arthritis Rheum 1979; 8: 223.Google Scholar
Uzun, O, Akpolat, T, Erkan, L. Pulmonary vasculitis in Behcet’s disease. Chest 2005; 127: 2243.Google Scholar
Bibliography
Devriese, PP, Schumacher, T, Scheide, A, et al. Incidence, prognosis and recovery of Bell’s palsy. Clin Otolaryngol 1990; 15: 15.Google Scholar
Halperin, J, Luft, BJ, Volkman, DJ, et al. Lyme neuroborreliosis: peripheral nervous system manifestations. Brain 1990; 113: 1207.Google Scholar
Murakami, S, Mizobuchi, M, Nakashiro, Y, et al. Bell palsy and herpes simplex virus identification of viral DNA in endoneurial fluid and muscle. Ann Intern Med 1996; 124: 27.Google Scholar
Mutsch, M, Zhou, W, Rhodes, P, et al. Use of the inactivated intranasal influenza vaccine and the risk of Bell’s palsy in Switzerland. N Engl J Med 2004; 350: 896.Google Scholar
Bibliography
Giuseffi, V, Wall, M, Siegel, PZ, et al. Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri). Neurology 1991; 41: 239.Google Scholar
Lyons, MK, Meyer, FB. Cerebrospinal fluid physiology and the management of increased intracranial pressure. Mayo Clin Proc 1990; 65: 684.Google Scholar
Bibliography
Blankenhorn, MA. The diagnosis of beriberi heart disease. Ann Intern Med 1945; 23: 398.Google Scholar
Bibliography
Balmes, JR, Abraham, JL, Dweik, RA, et al. An official American Thoracic Society statement: diagnosis and management of beryllium sensitivity and chronic beryllium disease. Am J Respir Crit Care Med 2014; 190: e34.Google Scholar
Infante, PF, Newman, LS. Beryllium exposure and chronic beryllium disease. Lancet 2004; 363: 415.Google Scholar
Kriebel, D, Brain, JD, Sprince, NL, et al. The pulmonary toxicity of beryllium. Am Rev Respir Dis 1988; 137: 464.Google Scholar
Lundgren, RA, Maier, LA, Rose, CS, et al. Indirect and direct gas exchange at maximum exercise in beryllium sensitization and disease. Chest 2001; 120: 1702.Google Scholar
MacMurdo, MG, Mroz, MM, Culver, DA, et al. Chronic beryllium disease: update on a moving target. Chest 2020; 158: 2458.Google Scholar
Rossman, MD, Kern, JA, Elias, JA, et al. Proliferative responses of bronchoalveolar lymphocytes to beryllium: a test for chronic beryllium disease. Ann Intern Med 1988; 108: 687.Google Scholar
Sood, A, Beckett, WS, Cullen, MR. Variable response to long-term corticosteroid therapy in chronic beryllium disease. Chest 2004; 126: 2000.Google Scholar
Bibliography
Heathcote, EJ. Management of primary biliary cirrhosis: the American Association for the Study of Liver Diseases practice guidelines. Hepatology 2000; 31: 1005.Google Scholar
James, SP, Hoofnagle, JH, Strober, W, et al. Primary biliary cirrhosis: a model autoimmune disease. Ann Intern Med 1983; 99: 500.Google Scholar
Poupon, RE, Poupon, R, Balkau, B. Ursodiol for the long-term treatment of primary biliary cirrhosis. N Engl J Med 1994; 330: 1342.Google Scholar
Bibliography
Bellomo, R, See, EJ. Novel renal biomarkers of acute kidney injury and their implications. Intern Med J 2021; 51: 316.Google Scholar
Legrand, M, Januzzi, JL, Mebazaa, A. Critical research on biomarkers: what’s new? Intens Care Med 2013; 39: 1824.Google Scholar
Moran, JL, Solomon, PJ. The search for biomarkers in the critically ill: a cautionary tale. Crit Care Resusc 2018; 20: 85.Google Scholar
Seymour, CW, Yende, S, Scott, MJ, et al. Metabolomics in pneumonia and sepsis: an analysis of the GenIMS cohort study. Intens Care Med 2013; 39: 1423.Google Scholar
Sweeney, TE, Khatri, P. Generalizable biomarkers in critical care: towards precision medicine. Crit Care Med 2017; 45: 934.Google Scholar
Various. Biomarkers in ICU: less is more? Yes, no, not sure. Intens Care Med 2021; 47: 94.Google Scholar
Bibliography
Antosia, R, Cahill, J, eds. Handbook of Bioterrorism and Disaster Medicine. Berlin: Springer. 2006.Google Scholar
Duchin, J, Malone, JD. Bioterrorism. In: Scientific American Medicine. Interdisciplinary Medicine. Hamilton: Dekker Medicine. 2020.Google Scholar
Karwa, M, Bronzert, P, Kvetan, V. Bioterrorism and critical care. Crit Care Clin 2003; 19: 279.Google Scholar
Kvetan, V, Farmer, JC, et al., eds. Critical care medicine for disasters, terrorism, and military conflict. Crit Care Med 2005; 33 (1, suppl.).Google Scholar
Rotz, LD, Khan, AS, Lillibridge, SR, et al. Public health assessment of potential bioterrorism agents. Emerg Infect Dis 2002; 8: 225.Google Scholar
Ursano, RJ, Norwood, AE, Fullerton, CS, eds. Bioterrorism: Psychological and Public Health Interventions. Cambridge: Cambridge University Press. 2004.Google Scholar
Waterer, GW, Robertson, H. Bioterrorism for the respiratory physician. Respirology 2009; 14: 5.Google Scholar
Wenzel, RP, Edmond, MB. Managing SARS amidst uncertainty. N Engl J Med 2003; 348: 1947.Google Scholar
Whitby, M, Ruff, TA, Street, AC, et al. Biological agents as weapons 2: anthrax and plague. Med J Aust 2002; 176: 605.Google Scholar
Bibliography
Abroug, F, Ouanes-Besbes, L, Tilouche, N, et al. Scorpion envenomation: state of the art. Intens Care Med 2020; 46: 401.Google Scholar
Bailey, PM, Little, M, Jetliner, GA, et al. Jellyfish envenoming syndromes: unknown toxic mechanisms and unproven therapies. Med J Aust 2003; 178: 34.Google Scholar
Berling, I, Isbister, GK. Hematologic effects and complications of snake envenoming. Transfus Med Rev 2015; 29: 82.Google Scholar
Bonefish, F, Jute, M, Belo, BM, et al. Prevention and treatment of Hymenoptera venom allergy: guidelines for clinical practice. Allergy 2005; 60: 1459.Google Scholar
Broacher, JR, Ravikumar, PR, Bania, T, et al. Treatment of toad venom poisoning with digoxin-specific Fab fragments. Chest 1996; 110: 1282.Google Scholar
Brooder, J, Jerald, D, Locker, J, et al. Low risk of infection in selected human bites treated without antibiotics. Am J Emerg Med 2004; 22: 10.Google Scholar
Burnett, JW, Calton, GJ. Jellyfish envenomation syndromes updated. Ann Emerg Med 1987; 16: 1000.Google Scholar
CSL Ltd. Treatment of Snake Bite in Australia and Papua New Guinea Using Antivenom. Melbourne: Commonwealth Serum Laboratories. 1992.Google Scholar
Cummings, P. Antibiotics to prevent infection in patients with dog bite wounds: a meta-analysis of randomized trials. Ann Emerg Med 1994; 23: 535.Google Scholar
Fanner, PJ, Haddock, JC. Fatal envenomation by jellyfish causing the Irukandji syndrome. Med J Aust 2002; 177: 362–363.Google Scholar
Fanner, PJ, Williamson, JA. Worldwide deaths and severe envenomation from jellyfish stings. Med J Aust 1996; 165: 658.Google Scholar
Fisher, MM, Carr, GA, McGuinness, R, et al. Atrax robustus envenomation. Anaesth Intens Care 1980; 8: 410.Google Scholar
Flicker, H. Irukandji sting to North Queensland bathers without production of weals but with severe general symptoms. Med J Aust 1952; 2; 89.Google Scholar
Griego, RD, Rosen, T, Orengo, IF, et al. Dog, cat, and human bites. J Am Acad Dermatol 1995; 33: 1019.Google Scholar
Hamilton, RG. Diagnostic methods for insect sting allergy. Cur Open Allergy Clin Immune 2004; 4: 297.Google Scholar
Having, S, Tulleken, JE, Moller, LVM, et al. Dog-bite induced sepsis: a report of four cases. Intens Care Med 1997; 23: 1179.Google Scholar
Healy, J, Winkel, KD, eds. Venom: Fear, Fascination and Discovery. Melbourne: Medical History Museum, University of Melbourne. 2013.Google Scholar
Huynh, TT, Seymour, J, Pereira, P, et al. Severity of Irukandji syndrome and nematocyst identification from skin scrapings. Med J Aust 2003; 178: 38.Google Scholar
Isbister, GK, Brown, SGA, Page, CB, et al. Snakebite in Australia: a practical approach to diagnosis and treatment. Med J Aust 2013; 199: 763.Google Scholar
Isbister, GK, Gray, MR. A prospective study of 750 definite spider bites with expert spider identification. QJM 2002; 95: 723.Google Scholar
Isbister, GK, Gray, MR. Latrodectism: a prospective cohort study of bites by formally identified red back spiders. Med J Aust 2003; 179: 88.Google Scholar
Isbister, GK, Gray, MR, Bali, CR, et al. Funnel-web spider bite: a systematic review of recorded clinical cases. Med J Aust 2005; 182: 407.Google Scholar
Isbister, GK, Volschenk, ES, Seymour, JE. Scorpion stings in Australia. Intern Med J 2004; 34: 427.Google Scholar
Isbister, GK, Whyte, IM. Suspected white-tail spider bite and necrotic ulcers. Intern Med J 2004; 34: 38.Google Scholar
Janda, DH, Ringler, DH, Hilliard, JK, et al. Nonhuman primate bites. J Orthop Res 1990; 8: 146.Google Scholar
Javaid, M, Feldberg, L, Gipson, M. Primary repair of dog bites to the face. J R Soc Med 1998; 91: 414.Google Scholar
Johnston, CI, Ryan, NM, Page, CB, et al. The Australian snakebite project, 2005–2015 (ASP-20). Med J Aust 2017; 207: 119.Google Scholar
MacBean, C, Taylor, DM, Ashby, K. Animal and human bite injuries in Victoria, 1998–2004. Med J Aust 2007; 186: 38.Google Scholar
McKinney, PE. Out-of-hospital and interhospital management of crotaline snakebite. Ann Emerg Med 2001; 37: 168.Google Scholar
Moffitt, JE, Golden, DB, Reiaman, RE, et al. Stinging insect hypersensitivity: a practice parameter update. J Allergy Clin Immunol 2004; 114: 869.Google Scholar
Pennell, TC, Babu, S-S, Meredith, JW. The management of snake and spider bites in the southeastern United States. Ann Surg 1987; 53: 198.Google Scholar
Pers, C, Gahrm-Hansen, B, Frederiksen, W. Capnocytophaga canimorsus septicaemia in Denmark, 1982–1995: review of 39 cases. Clin Infect Dis 1996; 23: 71.Google Scholar
Rodrigo, C, Gnanathasan, A. Management of scorpion envenomation: a systematic review and meta-analysis of controlled clinical trials. Syst Rev 2017; 6: 74.Google Scholar
Sutherland, SK, Coulter, AR, Harris, RD. Rationalisation of first-aid measures for elapid snakebite. Lancet 1979; 1: 183.Google Scholar
Sutherland, SK, Leonard, RL. Snakebite deaths in Australia 1992–1994 and a management update. Med J Aust 1995; 163: 616.Google Scholar
Sutherland, SK, Sutherland, J. Venomous Creatures of Australia. 5th edition. Melbourne: Oxford University Press. 2006.Google Scholar
Sutherland, SK, Tibbals, J. Australian Animal Toxins: The Creatures, Their Toxins and the Care of the Poisoned Patient. 2nd edition. Melbourne: Oxford University Press. 2001.Google Scholar
Sutherland, SK, Trinca, JC. Survey of 2144 cases of red-back spider bites: Australia and New Zealand, 1963–1976. Med J Aust 1978; 2: 620.Google Scholar
Tibballs, J. Diagnosis and treatment of confirmed and suspected snake bite. Med J Aust 1992; 156: 270.Google Scholar
Walker, JP. Venomous bites and stings. In: Scientific American Medicine. Interdisciplinary Medicine. Hamilton: Dekker Medicine. 2020.Google Scholar
White, J, Edmonds, C, Zborowski, P. Australia’s Most Dangerous Spiders, Snakes and Marine Creatures. Sydney: Australian Geographic. 2001.Google Scholar
Williamson, JA, Le Ray, LE, Wohlfahrt, M, et al. Acute management of serious envenomation by box-jellyfish (Chironex fleckeri). Med J Aust 1984; 141: 851.Google Scholar
Bibliography
Mathes, DD. Bleomycin and hyperoxia exposure in the operating room. Anesth Analg 1995; 81: 624.Google Scholar
Bibliography
Lee, P, Nair, P, Eisman, JA, et al. Bone failure in critical illness. Crit Care Med 2016; 44: 2270.Google Scholar
Bibliography
Arnon, SS, Schechter, R, Inglesby, TV, et al. Botulinum toxin as a biological weapon: medical and public health management. JAMA 2001; 285: 1059.Google Scholar
Hatheway, CL. Botulism: the present status of the disease. Curr Top Microbiol Immunol 1995; 195: 55.Google Scholar
Jankovic, J, Brin, MF. Therapeutic uses of botulinum toxin. N Engl J Med 1991; 324: 1186.Google Scholar
Lecour, H, Ramos, H, Almeida, B, et al. Food-borne botulism: a review of 13 outbreaks. Arch Intern Med 1988; 148: 578.Google Scholar
Merson, MH, Dowell, VR. Epidemiologic, clinical and laboratory aspects of wound botulism. N Engl J Med 1973; 289: 1005.Google Scholar
Whitby, M, Street, AC, Ruff, TA, et al. Biological agents as weapons 1: smallpox and botulism. Med J Aust 2002; 176: 431.Google Scholar
Bibliography
Agasthian, T, Deschamps, C, Trastek, VF, et al. Surgical management of bronchiectasis. Ann Thorac Surg 1996; 62: 976.Google Scholar
Mygind, N, Nielsen, MH, Pedersen, M. Kartagener’s syndrome and abnormal cilia. Eur J Respir Dis 1983; 64 (suppl. 127): 1.Google Scholar
Polverino, E, Goeminne, PC, McDonnell, MJ, et al. European Registry Society guidelines for the management of adult bronchiectasis. Eur Respir J 2017; 50: 1700629.Google Scholar
Visser, SK, Bye, P, Morgan, L. Management of bronchiectasis in adults. Med J Aust 2018; 209: 177.Google Scholar
Bibliography
Boehler, A, Kesten, S, Weder, W, et al. Bronchiolitis obliterans after lung transplantation: a review. Chest 1998; 114: 1411.Google Scholar
Epler, GR, Colby, TV, McLoud, TC, et al. Bronchiolitis obliterans organizing pneumonia. N Engl J Med 1985; 312: 152.Google Scholar
Ramirez, J, Dowell, AR. Silo-filler’s disease: nitrogen dioxide-induced lung injury: long-term follow-up and review of the literature. Ann Intern Med 1971; 74: 569.Google Scholar
Theodore, J, Starnes, VA, Lewiston, NJ. Obliterative bronchiolitis. Clin Chest Med 1990; 11: 309.Google Scholar
Bibliography
Alshabani, K, Ghosh, S, Arrossi, AV, et al. Broncholithiasis: a review. Chest 2019; 156: 445.Google Scholar
Kennedy, MP, Noone, PG, Cardon, J, et al. Calcium stone lithoptysis in primary ciliary dyskinesia. Respir Med 2007; 101: 76.Google Scholar
Bibliography
Fiori, PL, Mastrandrea, S, Rappelli, P, et al. Brucella abortus infection acquired in microbiology laboratories. J Clin Microbiol 2000; 38: 2005.Google Scholar
Liles, WC. Infections due to brucella, francisella, yersinia pestis, and bartonella. In: Scientific American Medicine. Infectious Diseases. Hamilton: Dekker Medicine. 2020.Google Scholar
Pappas, G, Akritidis, N, Bosilkovski, M, et al. Brucellosis. N Engl J Med 2005; 352: 2325.Google Scholar
Bibliography
Antzelevitch, C, Brugada, P, Borgreffe, M, et al. Brugada syndrome: report of the second consensus conference. Circulation 2005; 111: 659.Google Scholar
Brugada, P, Brugada, J. Right bundle branch block, persistent ST elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. J Am Coll Cardiol 1992; 20: 1391.Google Scholar
Carey, SM, Hocking, G. Brugada syndrome – a review of the implications for the anaesthetist. Anaesth Intens Care 2011; 39: 571.Google Scholar
Bibliography
Ageno, W, Dentali, F, Pomero, F, et al. Incidence rates and case fatality rates of portal vein thrombosis and Budd–Chiari Syndrome. Thromb Haemost 2017; 117: 794.Google Scholar
Bach, N, Thung, SN, Schaffner, F. Comfrey herb tea-induced hepatic veno-occlusive disease. Am J Med 1989; 87: 97.Google Scholar
Bearman, SI. The syndrome of hepatic veno-occlusive disease after marrow transplantation. Blood 1995; 85: 3005.Google Scholar
Broughton, BJ. Hepatic and portal vein thrombosis closely associated with myeloproliferative disorders. BMJ 1991; 302: 192.Google Scholar
Di Nisio, M, Valeriani, E, Riva, N, et al. Anticoagulant therapy for splanchnic vein thrombosis: ISTH SSC Subcommittee Control of Anticoagulation. J Thromb Haemost 2020; 18: 1562.Google Scholar
Klein, AS, Sitzmann, JV, Coleman, J, et al. Current management of the Budd–Chiari syndrome. Ann Surg 1990; 212: 144.Google Scholar
Kumar, S, DeLeve, LD, Kamath, PS, et al. Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation. Mayo Clin Proc 2003; 78: 589.Google Scholar
Mitchell, MC, Boitnott, JK, Kaufman, S, et al. Budd–Chiari syndrome: etiology, diagnosis and management. Medicine 1982; 61: 199.Google Scholar
Shulman, HM, Hinterberger, W. Hepatic veno-occlusive disease – liver toxicity syndrome after bone marrow transplantation. Bone Marrow Transpl 1992; 10: 197.Google Scholar
Valla, D, Casadevall, N, Lacombe, C, et al. Primary myeloproliferative disorder and hepatic vein thrombosis. Ann Intern Med 1985; 103: 329.Google Scholar
Vassal, G, Hartmann, O, Benhamou, E. Busulfan and veno-occlusive disease of the liver. Ann Intern Med 1990; 112: 881.Google Scholar
Wadleigh, M, Ho, V, Momtaz, P, et al. Hepatic veno-occlusive disease: pathogenesis, diagnosis and treatment. Curr Opin Hematol 2003; 10: 451.Google Scholar